FindTrial
Sign In

Construction and effect evaluation of a nurse-led remote symptom management program for Immune-related adverse events in Lung Cancer Patients

Construction and effect evaluation of a nurse-led remote symptom management program for Immune-related adverse events in Lung Cancer Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122465
Enrollment
Unknown
Registered
2026-04-14
Start date
2025-04-16
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Intervention Group:Nurse-led remote symptom management program for lung cancer immunotherapy-related adverse reactions (including theoretical construction, Delphi expert consultation revision, pilot s
Control Group:Routine symptom management (no specific intervention)

Sponsors

Affiliated Cancer Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Pathological histological examination confirmed lung cancer; 2.age>=18 years old; 3.about to receive immunotherapy, and the entire treatment will be conducted in the same hospital; 4.informed consent and voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: 1.Combine with other types of malignant tumors; 2.have a history of mental illness or cognitive, language, visual or auditory dysfunction.

Design outcomes

Primary

MeasureTime frame
Quality of Life;—

Countries

China

Contacts

Public ContactJiang Xue

Affiliated Cancer Hospital of Guangzhou Medical University

jiangxueyouxiang@163.com+86 177 0391 7696

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026